Stifel Financial's (NYSE:SF) total client assets rose 4% sequentially and 20% from a year ago to $513.9B at Nov. 30, 2024, ...

Barry Bannister, Stifel chief equity strategist, joins 'Squawk on the Street' to discuss why Bannister thinks the market was ...

Stifel analyst Selman Akyol upgraded DT Midstream, Inc. (NYSE:DTM) to Buy from Hold and raised the price target to $106 from ...

Stifel Financial Corp cut its holdings in Vital Energy, Inc. (NYSE:VTLE – Free Report) by 16.1% in the 3rd quarter, according ...

Stifel downgraded RxSight (RXST) to Hold from Buy with a price target of $40, down from $65. The firm’s latest deep-dive survey of surgeons ...

Stifel lowered the firm’s price target on Nike (NKE) to $75 from $79 and keeps a Hold rating on the shares. New CEO Elliott Hill, who rejoined ...

Cloudflare's stock rose premarket on Tuesday after Stifel upgraded the shares to Buy, citing improving execution, and strong ...

Stifel upgraded Denali Therapeutics (DNLI) to Buy from Hold with a $37 price target Denali recently aligned with the FDA to ...

Equity Commonwealth (EQC) stock saw a modest uptick, ending the day at $1.77 which represents a slight increase of $0.03 or 1.72% from the prior close of $1.74. The stock opened at $1.67 and touched a ...

Stifel lowered the firm’s price target on Sage Therapeutics (SAGE) to $6 from $10 and keeps a Hold rating on the shares. 2024 was “a challenging year,” with shares down about 75% following the failure ...

The Stifel Snow Show continues to bring fans unparalleled access to every sport on the FIS World Cup circuit, including ...

Micron’s stock plummeted on Thursday following the company’s earnings report and its weaker-than-expected guidance for the ...